← All stocks

Viridian Therapeutics, Inc.\DE

VRDN Net buying

CIK 0001590750 #1814 in the set updated 17 Sep 2026

Bought (12 mo)

$30.00M

out of their own pocket, the only kind of buying there is

Sold (12 mo)

$418.99K

$0.00 on a plan · $348.19K straight out of an exercise

Sold at will

$70.80K

1 of 3 sales

Net

+$29.58M

+$29.93M against sales at will

By person

6 insiders · 6 transactions

1.1×

Stephen Mahoney holds only 1.1 times base salary in stock. $811.69K of shares against $700.00K in salary for 2025.

Salary from the company's own proxy. The shares are what Stephen Mahoney last reported holding, valued at $24.50, the price Common Stock was last bought or sold at on the open market here, on 19 Aug 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Fairmount Funds Management LLC entity

Director

$30.00M (2)

—

+$30.00M

5,090,928

4.49%

$124.73M

+47.7%

Tousignant Jennifer

Chief Legal Officer

—

$418.99K (3) scheduled

−$418.99K

0.0000%

$0.00

−100.0%

Tripuraneni Radhika

Chief Medical Officer

—

40,000

0.0353%

$980.00K

—

Mahoney Stephen F.

President and CEO

—

33,130

0.0292%

$811.69K

+3,213%

Beetham Thomas W.

Chief Operating Officer

—

13,271

0.0117%

$325.14K

+563.6%

Harmon Seth

Chief Financial Officer

—

7,790

0.0069%

$190.86K

+115.6%

Individual transactions

Nothing of that kind in this period.

What was left out

Form 4 filings counted 16

Amendments (4/A) skipped 6

Filings about a different issuer 0

Unreadable filings 0

Joint filings 2

Sales on a Rule 10b5-1 plan 0

Sales straight out of an exercise 2

Sales at will 1

Transactions with no price 0

Shares from compensation/vesting 103,782

History held since 2 Nov 2016